PULSE BIOSCIENCES, INC. — Director's Dealing 2022

Feb 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-12-14

Reporting Person: GARDINER SANDRA A. (CFO & EVP Admin. and Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-14	Stock Option (right to buy)	$13.94	A	25961	Acquired	2029-11-18	Common Stock (25961)	Direct

Footnotes

F1: On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares.

F2: Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date.